Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still debated. METHODS: From August 2015 to October 2019,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Bavaro, Davide Fiore, Pizzutilo, Pamela, Catino, Annamaria, Signorile, Fabio, Pesola, Francesco, Di Gennaro, Francesco, Cassiano, Sandro, Marech, Ilaria, Lamorgese, Vito, Angarano, Gioacchino, Monno, Laura, Saracino, Annalisa, Galetta, Domenico
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Major Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8204890/
https://ncbi.nlm.nih.gov/pubmed/34141817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab187
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky